JF
CRDF icon

Jump Financial’s Cardiff Oncology CRDF Stock Holding History

Jump Financial’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-85,838
Closed -$191K – 1710
2024
Q2 		$191K Buy
+85,838
New +$323K ﹤0.01% 1572
2022
Q2 		– Sell
-41,600
Closed -$103K – 1678
2022
Q1 		$103K Buy
+41,600
New +$147K ﹤0.01% 1403
2021
Q3 		– Sell
-44,100
Closed -$293K – 1158
2021
Q2 		$293K Buy
+44,100
New +$374K 0.03% 684

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jump Financial's CRDF Position: Q3 2024 in Review

Jump Financial sold out of Cardiff Oncology (CRDF) in Q3 2024, closing a stake of 85,838 shares — an estimated $191K sold.

Jump Financial first reported a position in CRDF in Q2 2021 and held it in 3 quarters. The position peaked at $293K in Q2 2021. 83 funds tracked by Wall St. Rank hold CRDF as of Q3 2024.

  • Jump Financial reported no remaining Cardiff Oncology position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 85,838 Cardiff Oncology shares in Q3 2024, an estimated $191K.
  • Jump Financial first reported a position in Cardiff Oncology in Q2 2021 and held it in 3 quarters.
  • Jump Financial's Cardiff Oncology position peaked at $293K in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.